TBC1D1 |
MAP1LC3A |
||
---|---|---|---|
Gene Name | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 | microtubule-associated protein 1 light chain 3 alpha | |
Image | |||
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process | |||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS | |||
Protein-Protein Interactions | 4 interactors: GABARAPL1 MAP1LC3A SMAD2 YWHAG | 40 interactors: AKAP13 APP ATG101 ATG13 ATG3 ATG4B ATG7 BNIP3L DVL2 EPHA7 FAM134C FUNDC1 KIF15 KXD1 MAP1A MAP1S NBR1 OPTN PIAS4 PRPF40A RABGAP1 RABGAP1L RDH12 RTKN SQSTM1 SRPK1 TBC1D1 TBC1D10A TBC1D10B TBC1D16 TBC1D17 TBC1D2 TBC1D25 TBC1D2B TBC1D5 TBC1D7 TBC1D9 TBC1D9B TNIP1 TUBA4A | |
Entrez ID | 23216 | 84557 | |
HPRD ID | 18161 | 03144 | |
Ensembl ID | ENSG00000065882 | ENSG00000101460 | |
Uniprot IDs | B9A6J6 Q6PJJ8 Q86TI0 Q8NC59 | Q9H492 | |
PDB IDs | 3QYE | 3ECI | |
Enriched GO Terms of Interacting Partners? |
|
|
|
Tagcloud ? | adaptor
alanine
appl1
appl2
bar
conditional
diminishes
elusive
evoked
fine
glut4
gtpase
homolog
hyperglycemia
likewise
muscles
myotubes
partner
potentiates
rab
serine
skeletal
stimulates
substitution
suppresses
suppressive
threonine
tune
uptake
|
acquiring
adenocarcinoma
autophagy
became
came
constitutive
date
demethylation
egfr
erlotinib
escaping
exposing
gefitinib
ie
immunoreactivity
necessarily
neoplastic
novo
overcoming
parental
pc9
pivotal
predictor
pronounced
restores
tkis
treating
tumoural
|
|
Tagcloud (Difference) ? | adaptor
alanine
appl1
appl2
bar
conditional
diminishes
elusive
evoked
fine
glut4
gtpase
homolog
hyperglycemia
likewise
muscles
myotubes
partner
potentiates
rab
serine
skeletal
stimulates
substitution
suppresses
suppressive
threonine
tune
uptake
|
acquiring
adenocarcinoma
autophagy
became
came
constitutive
date
demethylation
egfr
erlotinib
escaping
exposing
gefitinib
ie
immunoreactivity
necessarily
neoplastic
novo
overcoming
parental
pc9
pivotal
predictor
pronounced
restores
tkis
treating
tumoural
|
|
Tagcloud (Intersection) ? |